Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Joseph

Showing results (461-470 of 531) with videos related to

Pageof 54
Sort By:
The Journal of Rheumatology|June 19, 2012
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trialW Winn Chatham, Daniel J Wallace, William Stohl, et al.
JCI Insight|July 15, 2021
Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in miceDaniela Nasteska, Federica Cuozzo, Katrina Viloria, et al.
Arthritis and Rheumatism|August 29, 2009
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosusDaniel J Wallace, William Stohl, Richard A Furie, et al.
Cancer Cell|November 17, 2012
Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomasPiro Lito, Christine A Pratilas, Eric W Joseph, et al.
Diseases of Aquatic Organisms|February 26, 2026
Wild-type cutoff values for standard broth microdilution antimicrobial susceptibility testing of Yersinia ruckeri isolatesCharles M Gieseker, Matthew E Saab, Timothy J Welch, et al.
The Journal of Rheumatology|October 9, 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic eventJodi K Sebastian, Barbara Voetsch, John H Stone, et al.
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentJonathan A Sugam, Seth Robey, Sokreine Suon, et al.
The American Journal of Emergency Medicine|December 13, 2023
Code De-Escalation: Decreasing restraint use during agitation management in a community hospital emergency departmentDana D Im, Alice K Bukhman, Josh W Joseph, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Pageof 54

Showing results (461-470 of 531) with videos related to

Sort By:
Pageof 54
The Journal of Rheumatology|June 19, 2012
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trialW Winn Chatham, Daniel J Wallace, William Stohl, et al.
JCI Insight|July 15, 2021
Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in miceDaniela Nasteska, Federica Cuozzo, Katrina Viloria, et al.
Arthritis and Rheumatism|August 29, 2009
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosusDaniel J Wallace, William Stohl, Richard A Furie, et al.
Cancer Cell|November 17, 2012
Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomasPiro Lito, Christine A Pratilas, Eric W Joseph, et al.
Diseases of Aquatic Organisms|February 26, 2026
Wild-type cutoff values for standard broth microdilution antimicrobial susceptibility testing of Yersinia ruckeri isolatesCharles M Gieseker, Matthew E Saab, Timothy J Welch, et al.
The Journal of Rheumatology|October 9, 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic eventJodi K Sebastian, Barbara Voetsch, John H Stone, et al.
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentJonathan A Sugam, Seth Robey, Sokreine Suon, et al.
The American Journal of Emergency Medicine|December 13, 2023
Code De-Escalation: Decreasing restraint use during agitation management in a community hospital emergency departmentDana D Im, Alice K Bukhman, Josh W Joseph, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Pageof 54